2012 annual financial data

Theravance Biopharma 2012 Financial results

Theravance Biopharma 2012 financial results with verified reported values.

Direct answer

Revenue was 130,145,000 USD.

Operating income was -9,575,000 USD and net income was -9,575,000 USD.
Operating cash flow was -119,107,000 USD.

Get free Theravance Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
130,145,000 USD
Operating income
-9,575,000 USD
Net income
-9,575,000 USD
Operating cash flow
-119,107,000 USD